Christina Yap

Activities

  1. 2018
  2. A Phase II Clinical Trial with Efficacy and Toxicity Outcomes and Baseline Covariates

    Kristian Brock (Speaker), , Lucinda Billingham (Contributor), , Gary Middleton (Contributor), & Christina Yap (Contributor)

    2 Jul 2018

    Activity: Talk or presentationAcademic conference

  3. Implementing more novel designs in cancer clinical trials: the Birmingham experience

    Lucinda Billingham (Presenter), , Christina Yap (Presenter), , Kristian Brock (Presenter), & Daniel Slade (Presenter)

    26 Mar 2018

    Activity: Talk or presentationInvited talk

  4. 2017
  5. Assessing the design of our trial in an ultra-rare condition by the Parmar et al framework for trials in smaller populations

    Kristian Brock (Speaker), , Lucinda Billingham (Contributor), , Christina Yap (Contributor), & Timothy Barrett (Contributor)

    10 Jul 2017

    Activity: Talk or presentationAcademic conference

  6. 2015
  7. Application of Bayesian methods in the design and analysis of clinical trials

    Lucinda Billingham (Invited speaker), , Christina Yap (Invited speaker), & Kristian Brock (Invited speaker)

    16 Nov 201517 Nov 2015

    Activity: Talk or presentationAcademic conference